Mesoporous Organosilica-Based Hydrogen Sulfide Nanogenerator for Enhanced Tumor Chemotherapy
Jian Xu,Weichu Zhu,Xianxian Yao,Shuting Mai,Chenzi Li,Minghua Zhang,Dan Shu,Wuli Yang
DOI: https://doi.org/10.1021/acsanm.3c01824
IF: 6.14
2023-01-01
ACS Applied Nano Materials
Abstract:Conventionalchemotherapy is bothered by systematic toxicityandconfined therapeutic effects. Gas therapy has emerged as a potenttumor treatment, and hydrogen sulfide (H2S), a traditionalgasotransmitter, has been found to show a tumor inhibition effect.Therefore, we established a mesoporous organosilica-based H2S nanogenerator (MON-TPGS-DOX). Tetrasulfide bond-incorporated mesoporousorganosilica nanoparticles were modified with d-alpha-tocopherylpolyethylene glycol succinate (TPGS), namely, MON-TPGS, and then loadedwith doxorubicin (DOX) to obtain the nanogenerator. Tetrasulfide bondsin the nanogenerator could be triggered by glutathione (GSH) to releaseH(2)S, further resulting in the degradation of nanogeneratorand DOX release. GSH consumption and H2S release led tooxidative stress in 4T1 cells, activation of apoptotic signaling cascades,and enhanced cell-killing effect. Furthermore, the nanogenerator effectivelysuppressed tumor growth in a tumor-bearing mice model with good biosafety,providing a promising approach for H2S-enhanced tumor chemotherapy.